Regulatory approval for Asahi Kasei-Calliditas deal by mid-2024? | Binary | | | 7 months ago | |
Asahi Kasei's pharmaceutical revenue up significantly by end of 2025? | Binary | | | 7 months ago | |
Impact on Asahi Kasei's stock price post-Calliditas acquisition announcement | Categorical | | | 7 months ago | |
Number of pharmaceutical acquisitions by Asahi Kasei by end of 2025 | Categorical | | | 7 months ago | |
Asahi Kasei completes acquisition of Calliditas by end of 2024? | Binary | | | 7 months ago | |
Will Myricx Pharma start Phase 1 clinical trials for NMTi-ADC therapeutics by end of 2024? | Binary | | | 6 months ago | |
Market position of Asahi Kasei's pharma sector by end of 2025 | Categorical | | | 7 months ago | |
Will Asceneuron announce a partnership with a major pharmaceutical company by the end of 2024? | Binary | | | 5 months ago | |
How much will Asceneuron raise in its next major funding round by the end of 2025? | Categorical | | | 5 months ago | |
Will Myricx Pharma secure additional funding or partnerships by mid-2025? | Binary | | | 6 months ago | |
Will Myricx Pharma's NMTi-ADC therapeutics show positive results in preclinical studies by Q1 2025? | Binary | | | 6 months ago | |
How much additional funding will Myricx Pharma secure by mid-2025? | Categorical | | | 6 months ago | |
Will Asceneuron successfully complete Phase 2 clinical trials for ASN51 by the end of 2025? | Binary | | | 5 months ago | |
Will Asceneuron's ASN51 receive Fast Track designation from the FDA by the end of 2024? | Binary | | | 5 months ago | |
What will be the outcome of Asceneuron's Phase 2 clinical trials for ASN51 by the end of 2025? | Categorical | | | 5 months ago | |
What will be the regulatory approval status of Asceneuron's ASN51 in the EU by the end of 2026? | Categorical | | | 5 months ago | |
What will be the first indication for Myricx Pharma's NMTi-ADC therapeutics in clinical trials by end of 2024? | Categorical | | | 6 months ago | |
What will be Myricx Pharma's next major milestone in NMTi-ADC therapeutics development by end of 2024? | Categorical | | | 6 months ago | |
